Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron)



Similar documents
Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

There is a risk of renal impairment in dehydrated children and adolescents.

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

Package leaflet: Information for the patient. Donecept 5 mg film-coated tablets Donecept 10 mg film-coated tablets. Donepezil hydrochloride

PACKAGE LEAFLET

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)

1 What Zofran Solution for Injection or Infusion is and what it is used

PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine

Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

1. What Olanzapine Tablets is and what it is used for

1. What Xylocaine with adrenaline is and what it is used for

PATIENT INFORMATION LEAFLET

Package leaflet : information for the user. Dilute Adrenaline/Epinephrine Injection 1:10,000 adrenaline (epinephrine) (as acid tartrate) 0.

MEDICATION GUIDE. TRINTELLIX [trin -tel-ix] (vortioxetine) Tablets

(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)

UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride

Package Leaflet: Information for the user. <Levetiracetam 750 mg, film-coated tablets> <Levetiracetam 1000 mg, film-coated tablets> Levetiracetam

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

What is in this leaflet. 3. How to take Zimovane 4. Possible side effects 5. How to store Zimovane 6. Contents of the pack and other information

2 What you need to know before you have Ampiclox

Package leaflet: Information for the user. CIALIS 20 mg film-coated tablets Tadalafil

Amlodipine 5 and 10 mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

1. What Malarone is and what it is used for

Package leaflet: Information for the patient. Tramadol hydrochloride/paracetamol 37.5 mg/325 mg Film-coated Tablets

XARELTO (Za-REL-toe) rivaroxaban

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET Page 1 of 7

XARELTO (Za REL toe) rivaroxaban

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets. Metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Package leaflet: Information for the patient. Cholecalciferol mibe 500 IE, tabletten Cholecalciferol. For use in infants, children and adults

Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

Package leaflet: Information for the user

Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (HCl) STEROP 0,8mg/1ml. Solution for injection. Adrenaline (Levorenine, Epinephrine)

Patient Medication Guide Brochure

Bisoprolol Fumarate 2.5mg, 5mg & 10mg Tablets

What Codeine Phosphate Tablets are used for

1 What Anapen is and what it is used for?

MEDICATION GUIDE POTIGA (po-tee-ga) tablets, CV (ezogabine)

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember.

Package leaflet: Information for the user. Maxtrex 2.5mg Tablets methotrexate

Package leaflet: Information for the patient. ZITHROMAX 250 mg Capsules azithromycin

Read all of this leaflet carefully before you start taking this medicine

PATIENT INFORMATION LEAFLET. Forceval Capsules

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets

MEDICATION GUIDE. TOPAMAX (TOE-PA-MAX) (topiramate) Tablets and Sprinkle Capsules

Share the important information in this Medication Guide with members of your household.

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) Tablets

11 Serious and life-threatening side effects can occur while taking EVISTA. These include 12 blood clots and dying from stroke:

MEDICATION GUIDE. (topiramate) Tablets. Sprinkle Capsules

MEDICATION GUIDE. Bupropion Hydrochloride (bue-proe-pee-on HYE-droe-KLOR-ide) Extended-Release Tablets, USP (SR)

PATIENT INFORMATION LEAFLET. Forceval Junior Capsules

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

P AC K AG E L E AF L E T: INFORMAT I ON FO R THE USER. 500 mg, film-coated tablet Active substance: metformin hydrochloride

Perfalgan 10 mg/ml, solution for infusion

MALARONE Tablets (250/100) MALARONE Junior Tablets (62.5/25) MALARONE (Atovaquone and Proguanil Hydrochloride)

Package leaflet: Information for the user. Xarelto 10 mg film-coated tablets Rivaroxaban

Package leaflet: Information for the patient

MRP-No. DE/H/0279/001/P/002 Dr. Scheffler Vitamin C, 1000mg, effervescent tablets

MEDICATION GUIDE. Tranxene* (TRAN-zeen) T-TAB (clorazepate dipotassium) tablets

Package leaflet: Information for the patient Sativex Oromucosal Spray. (delta-9-tetrahydrocannabinol and cannabidiol)

Important: Please Read PART III: CONSUMER INFORMATION

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

Medication Guide Korlym (KOR-lim) (mifepristone) tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 2.5 mg Tablets

This leaflet answers some common questions about ARROW - MELOXICAM.

2 What you need to know before you use Imigran nasal spray

PRODUCT MONOGRAPH. Pr PROLOPA. levodopa and benserazide combination. Capsules , , Pharmaceutical standard: professed

STRATTERA (Stra-TAIR-a)

PACKAGE LEAFLET: INFORMATION FOR THE USER. METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride

NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam

Motilium 1mg/ml Oral Suspension Domperidone

APO-Tramadol SR Contains the active ingredient, tramadol (as tramadol hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

A PATIENT S GUIDE TO STROKE AND ATRIAL FIBRILLATION (AF)

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

Transcription:

Package leaflet: Information for the user Ondemet 4mg and 8mg Tablets (Ondansetron) Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor, or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Ondansetron is and what it is used for 2. What you need to know before you take Ondansetron 3. How to take Ondansetron 4. Possible side effects 5. How to store Ondansetron 6. Contents of the pack and other information 1. What Ondansetron is and what it is used for Ondansetron belongs to a group of drugs called anti-emetics. Ondansetron inhibits the effect of the neuro-transmitter serotonin in the brain. Serotonin causes nausea and vomiting. Ondansetron is used for: Preventing and treating nausea and vomiting induced by cytotoxic chemotherapy (CINV) and radiotherapy (adults and children aged 6 months). Preventing and treating nausea and vomiting in patients following an operation (PONV) (in adults and children aged 1 month). Your doctor may have prescribed Ondansetron for another use. Always follow your doctor's advice. 2. What you need to know before you take Ondansetron Do not take Ondansetron: if you are allergic to Ondansetron or any of the other ingredients of this medicine (listed in section 6)

if you have previously experienced allergy to other drugs belonging to the group of serotonin antagonists (e.g. granisetron, dolasetron). If this is the case, it is possible that you are also allergic to Ondansetron if you are taking apomorphine (used to treat Parkinson's disease). Warnings and precautions Talk to your doctor or pharmacist before taking Ondansetron: if you have a blockage of your intestines or constipation, as you will need to be closely monitored by your doctor if you are going to have or recently have had your tonsils removed, because treatment with Ondansetron may hide symptoms of internal bleeding if you have problems with the levels of salts in your blood such as potassium and magnesium if you have heart problems, such as irregular heartbeat (with arrhythmias or conduction disorders) and are being treated with other medication such as anaesthetics, anti-arrhythmics or beta-blockers at the same time, because of the limited experience hereby if it is for children below the age of 6 months or with a body surface of less than 0.6 m 2 if you have liver problems if children or adolescents receive ondansetron together with drugs, that may have a harmful effect on the liver. Careful monitoring of the liver function is recommended if you take other serotonergic drugs (medicines of the type SSRI or SNRI, used in the treatment of depressions). Tell your doctor if any of the above warnings apply to you. Please tell your doctor or nurse if you need to have blood or urine tests, that you are being treated with Ondansetron. Other medicines and Ondansetron Ondansetron may have an effect on other drugs or other drugs may have an effect on Ondansetron. Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. You must tell your doctor that you are taking Ondansetron, if he/she starts treating you with the following medicine: Drugs for epilepsy (phenytoin, carbamazepine), which may reduce the effect of ondansetron Antibiotics and antifungal medicines (e.g. rifampicin, erythromycin or ketoconazole) Pain relieving medicine (tramadol) Apomorphine (used to treat Parkinson s disease) Medicines inducing heart damage (e.g. anthracyclines or trastuzumab) Serotonergic drugs (medicines of the type SSRI or SNRI, used in the treatment of depressions) Anti-arrhythmic medicines used to treat an uneven heart beat (e.g. amiodarone)

Drugs which may result in QT prolongation (heart rhythm disorder) Beta-blocker medicines used to treat certain heart or eye problems, anxiety or prevent migraines (e.g. atenolol or timolol). Talk with your doctor or the healthcare staff if you are taking any of these types of medicines. It may be necessary to adjust the dose. Taking Ondansetron with food and drink You may take Ondansetron with food and drinks. The tablets should be taken with a glass of water. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Pregnancy: Use in pregnancy has not been established and is not recommended. If it is absolutely necessary that ondansetron be given, caution should be exercised when prescribing to pregnant women especially in the first trimester. Your doctor should evaluate the risk/benefit balance. Breast-feeding: Do not take Ondansetron if you are breast-feeding, because it is excreted into the milk. Driving and using machines Ondansetron does not affect the ability to use any tools or machines or the ability to drive safely in traffic. Ondansetron contains lactose If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. 3. How to take Ondansetron Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Treatment and prevention of nausea and vomiting in connection with chemotherapy or radiotherapy Adults: The recommended oral dose is 8 mg 1-2 hours before chemotherapy or radiotherapy, followed by 8 mg every 12 hours for up to 5 days. Your doctor may decide to give the first dose as an injection. Elderly: The same dose as for adults. Paediatric population (children aged 6 months and adolescents): Ondansetron should be given immediately before chemotherapy as a single dose given into a vein. Oral dosing can commence twelve hours later and may be continued for up to 5 days. The total daily dose must not exceed 32 mg.

Treatment and prevention of post-operative nausea and vomiting Adults: The recommended oral dose is 16 mg one hour prior to anaesthesia or alternatively, 8 mg taken one hour prior to anaesthesia followed by an additional 8 mg after 8 and 16 hours. Your doctor may choose to give you the medicine as injections. Elderly: There is limited experience with the use of ondansetron in elderly patients. Ondansetron is however tolerated well by patients above 65 years in chemotherapy (please refer to sections above). Paediatric population (children aged 1 month and adolescents): For prevention of PONV in paediatric patients having surgery performed under general anaesthesia, a single dose of ondansetron may be given by slow injection into a vein. For the treatment of PONV after surgery in paediatric patients having surgery performed under general anaesthesia, a single dose of ondansetron may be given by slow injection into a vein. There are no data on the use of ondansetron in the treatment of PONV in children below 2 years of age. Insufficient function of the liver: The daily dose should not exceed 8 mg if you have moderately to severely reduced function of the liver. The tablets should be taken with a glass of water. Always follow your doctor's prescription. There are differences in what the individual patients need. Changes in or discontinuation of treatment should only occur in consultation with your doctor. If you take more Ondansetron than you should If you or your child take more Ondansetron than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you. The symptoms of overdose are disturbances of vision, severe constipation, low blood pressure and disturbances in heart beat rhythm. If you forget to take Ondansetron Do not take a double dose to make up for a forgotten dose. 4. Possible side effects Like all medicines, Ondansetron can cause side effects, although not everybody gets them. Very common side effects (may affect more than 1 in 10 people): headache. Common side effects (may affect up to 1 in 10 people): a sensation of reddening and warmth

constipation local injection site reactions (if you use Ondansetron injection). Uncommon side effects (may affect up to 1 in 100 people): seizures hiccups low blood pressure irregular heartbeats heart pain and slow pulse involuntary movements sometimes changes in liver function have been observed. Rare side effects (may affect up to 1 in 1000 people): sudden skin rash, difficulty breathing, and fainting (within minutes to hours) due to hypersensitivity (anaphylactic shock) dizziness (usually during rapid injection of Ondansetron) transient visual disturbances such as blurred vision (usually during rapid injection of Ondansetron) Prolongation of QT-time in ECG, including abnormally rapid heart rhythm called Torsade des pointes. If any of these symptoms occur, immediately seek medical attention. Very rare side effects (may affect up to 1 in 10, 000 people): temporary blindness usually during injection of Ondansetron. Most of these blindness cases were resolved within 20 minutes. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the internet at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Ondansetron Keep out of the sight and reach of children Store in the original package Do not use Ondansetron after the expiry date which is stated on the blister and on the carton. The expiry date refers to the last day of that month Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Ondansetron contains The active substance is ondansetron 4 mg or 8 mg as ondansetron hydrochloride dihydrate. The other ingredients are Cellulose, microcrystalline; Lactose monohydrate; Starch, pregelatinised (maize); Magnesium stearate; Hypromellose; Hydroxypropylcellulose; Propylene glycol; Sorbitane oleate; Sorbic acid; Vanillin; Titanium dioxide (EI7l) and Quinoline yellow (E I04).

What Ondansetron looks like and contents of the pack Ondemet 4 mg are yellow round, biconvex film-coated tablets with a diameter of 7.2 mm and marked 41 on one side. Ondemet 8 mg are yellow round, biconvex film-coated tablets with a diameter of 9.2 mm and marked 42 on one side. 4 mg blister: 6, 10, 30, 50 and 100 film-coated tablets. 8 mg blister: 6, 10, 15, 30, 50 and 100 film-coated tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, UK Manufacturer Pharmathen S.A., 6. Dervenakion str., 15351 Pallini. Attikis, Greece This leaflet was last revised in January 2016 Ondemet is a registered trademark in the United Kingdom of Alliance Pharmaceuticals Limited. Alliance and associated devices are registered trademarks of Alliance Pharmaceuticals Limited. Alliance Pharmaceuticals Limited 2016 ALLIANCE LOGO